West Pharmaceutical Services, Inc. (WST)
245.30
+1.08
(+0.44%)
USD |
NYSE |
Feb 24, 09:33
West Pharmaceutical Services Research and Development Expense (Quarterly) : 21.80M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 352.90M |
| Becton, Dickinson & Co. | 306.00M |
| Boston Scientific Corp. | 569.00M |
| Abbott Laboratories | 721.00M |
| Baxter International, Inc. | 116.00M |